Bortezomib, Dexamethasone, and High-Dose Melphalan as Conditioning for Stem Cell Transplantation in Young Japanese Multiple Myeloma Patients: A Pilot Study

Por Takezako, Naoki, Sekiguchi, Naohiro, Nagata, Akihisa, Homma, Chiho, Noto, Satoshi, Miwa, Akiyoshi
Publicado em 2012

Soluble ST2 protein inhibits LPS stimulation on monocyte-derived dendritic cells

Por Nagata, Akihisa, Takezako, Naoki, Tamemoto, Hiroyuki, Ohto-Ozaki, Hiromi, Ohta, Satoshi, Tominaga, Shin-ichi, Yanagisawa, Ken
Publicado em 2012

Carfilzomib, lenalidomide and dexamethasone in patients with heavily pretreated multiple myeloma: A phase 1 study in Japan

Por Suzuki, Kenshi, Ri, Masaki, Chou, Takaaki, Sugiura, Isamu, Takezako, Naoki, Sunami, Kazutaka, Ishida, Tadao, Izumi, Tohru, Ozaki, Shuji, Shumiya, Yoshihisa, Ota, Kenji, Iida, Shinsuke
Publicado no Cancer Sci (2017)

Lenalidomide and low‐dose dexamethasone in Japanese patients with newly diagnosed multiple myeloma: A phase II study

Por Suzuki, Kenshi, Shinagawa, Atsushi, Uchida, Toshiki, Taniwaki, Masafumi, Hirata, Hirokazu, Ishizawa, Kenichi, Matsue, Kosei, Ogawa, Yoshiaki, Shimizu, Takayuki, Otsuka, Maki, Matsumoto, Morio, Iida, Shinsuke, Terui, Yasuhito, Matsumura, Itaru, Ikeda, Takashi, Takezako, Naoki, Ogaki, Yumi, Midorikawa, Shuichi, Houck, Vanessa, Ervin‐Haynes, Annette, Chou, Takaaki
Publicado no Cancer Sci (2016)